Macrophage migration inhibitory factor as a potential biomarker in acetaminophen overdose: a pilot study

Abstract

AbstractAcetaminophen overdose is a leading cause of liver failure in the United States. Macrophage migration inhibitory factor (MIF) is a cytokine that is released early and promotes acetaminophen toxicity in preclinical models. This cytokine could prove a useful biomarker in emergency department (ED) patients immediately following an acute acetaminophen overdose. We selected a convenience sample of thirteen patients from a prospective consecutive cohort of ED patients with suspected acute overdose. Research associates collected waste specimens for MIF analysis that remained after use for clinical care. Our team compared patients with confirmed acetaminophen overdose (n = 9) to patients without acetaminophen exposure or liver injury (n = 3) and a patient with liver injury in the absence of detectable acetaminophen (n = 1). In our acetaminophen group, all nine patients had measurable acetaminophen concentrations. Median MIF serum concentrations were 16.08 ng/mL (In this pilot study, MIF was feasible to measure in specimens from an ED drug overdose cohort, and was significantly elevated in the acetaminophen group compared to non-acetaminophen controls without liver injury.

Keywords

• Migration inhibitory factor
• acetaminophen
• biomarker
• overdose
• liver